Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07032506 · ClinicalTrials.gov registry record · NA
Intrauterine Stent Placement Following Hysteroscopic Septum Resection
A NA study, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- NA
- Development phase
- 320
- Enrollment target
NCT07032506: Recruiting NA study, sponsored by Weill Medical College of Cornell University.
NCT07032506 is a NA study that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 320 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07032506, a NA study, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- NA
- Development phase
- 320 participants
- Enrollment target
Study Summary
The study hopes to learn the best way to prevent internal scar tissue after septum removal. The use of an intrauterine foley catheter balloon may prevent the formation of adhesions following surgery.
Interventions
- PROCEDURE Intraoperative placement of an inflated intrauterine pediatric foley catheter
- PROCEDURE No Catheter placement
- DRUG Hormonal Therapy Agent
- DRUG Oral antibiotics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2026-05-14 |
| Est. Completion | 2031-12-31 |
| Phase | NA |
What NCT07032506 shows while recruiting
NCT07032506 is an interventional study that assigns participants to a tested intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 4 interventions - of which Intraoperative placement of an inflated intrauterine pediatric foley catheter is the first listed.
NCT07032506 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07032506 about?
NCT07032506 is a clinical study titled "Intrauterine Stent Placement Following Hysteroscopic Septum Resection". The study hopes to learn the best way to prevent internal scar tissue after septum removal. The use of an intrauterine foley catheter balloon may prevent the formation of adhesions following surgery.
What is the current status of trial NCT07032506?
This trial is currently recruiting. It is a NA study. The enrollment target is 320 participants. The study started on 2026-05-14. Estimated completion is 2031-12-31.
What interventions are being tested in trial NCT07032506?
The interventions under investigation include: Intraoperative placement of an inflated intrauterine pediatric foley catheter (PROCEDURE), No Catheter placement (PROCEDURE), Hormonal Therapy Agent (DRUG), Oral antibiotics (DRUG).
Who is sponsoring clinical trial NCT07032506?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07032506's enrollment target sits among peer trials
320 315th of 2000 higher than 1,680 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
- NCT03551951 · 320 participants
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI